Stop Margin Leakage at the Point of Dispense
Vistaar provides intelligent price recommendations designed to capture every available dollar from PBM reimbursements while keeping prices attractive to cash customers. Use this Quick Start pilot to check our recommendations against your prices, using your actual transaction data; at no cost and with no commitment.
Validate Your Margin Potential Immediately
We analyze your history for 10 high-volume generics to calculate reimbursement potential.
- Identify specific prescriptions where PBMs paid you less than they should have because of your current shelf price.
- Receive price recommendations tailored to your local competitors (GoodRx, Walmart) to win customers without sacrificing margin.
- See a projected dollar-value profit gain based on your actual sales volume.
- Model the revenue impact and preview the results before you publish a single price change to your stores.
How It Works
Export Your Data
Generate a transaction report (Excel or CSV) from your pharmacy management system for the 10 target drugs. We require the most recent 4 weeks of history, though more data yields higher accuracy.
Secure Upload
Submit your file via our secure, HIPAA-compliant portal. No direct integration or installation is required on your terminals.
Review Your Strategy
Within a day, you will receive a strategy document outlining the optimal price points and the mathematical models used to derive them.
Who this is for
Retail pharmacies managing inventory and margins under pressure.
Complimentary Trial Drug List
The pilot focuses on these 10 commonly dispensed generics where price elasticity and reimbursement caps frequently cause margin leakage. You should include data for any NDC you dispense for these drugs.
Esomeprazole 40mg DR
Aripiprazole 5mg Tablets
Breyna 160/4.5 Aer
Scopolamine 1mg/3day DIS
Varenicline 1mg Tablets
Benzonatate 200mg Capsules
Albuterol 90mcg Inhaler
Mirabegron ER 50mg Tablets
Dexlansoprazole 60mg DR
Icosapent 1gm Capsules
Frequently Asked Questions
No. We strictly analyze transaction financials (price, cost, reimbursement). Please scrub patient names and IDs before uploading.
No, absolutely not. This is a complimentary, risk-free trial. We are confident the value we demonstrate on these 10 drugs will validate the service, and you can choose to explore our full service offerings afterwards.
Typically, the recommendations are returned in about 1 business day after your data is successfully processed. If the data requires correction, one of our consultants will reach out immediately via the provided email.
If you don’t know the individual transaction's GER, we can apply some generic rules. For example, we might assume the GER Adjustment is AWP less a fixed percentage, minus the Reimbursement and Copay paid for the transaction. This allows us to accurately model the true potential.
Vistaar will provide you with a dedicated contact email when we deliver your recommendations. You can reach out directly to a consultant in case you have any questions about the analysis or results.
No. This Quick Start is a data-in, insights-out analysis. If you choose to adopt the full Vistaar platform later, we offer deeper integration options, but they are not required for this analysis.
